XTL Biopharmaceuticals Ltd ADR (XTLB) — Tangible Net Worth Ratio
XTL Biopharmaceuticals Ltd ADR (XTLB) has a Tangible Net Worth Ratio of 29.8% as of March 2025. This metric is calculated by deducting intangible assets ($3.82 Million) from net assets ($5.43 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital to net assets of XTL Biopharmaceuticals Ltd ADR to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
XTL Biopharmaceuticals Ltd ADR Tangible Net Worth Ratio (2002–2024)
This chart shows how XTL Biopharmaceuticals Ltd ADR's Tangible Net Worth Ratio has changed across 23 annual periods from 2002 to 2024. As of March 2025, the ratio stands at 29.8%, reflecting net assets of $5.43 Million with intangible assets of $3.82 Million USD. See defensive interval ratio of XTL Biopharmaceuticals Ltd ADR to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for XTL Biopharmaceuticals Ltd ADR (2002–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for XTL Biopharmaceuticals Ltd ADR from 2002 to 2024, covering 23 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see XTLB market cap.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 29.8% | $5.43 Million | $3.82 Million | $8.55 Million | ▼ -53.1 pp |
| 2023 | 82.9% | $2.22 Million | $380.00K | $2.43 Million | ▼ -7.6 pp |
| 2022 | 90.5% | $4.00 Million | $380.00K | $4.19 Million | ▼ -2.4 pp |
| 2021 | 92.9% | $5.33 Million | $380.00K | $6.62 Million | ▼ -1.0 pp |
| 2020 | 93.9% | $6.25 Million | $380.00K | $6.50 Million | ▼ -0.6 pp |
| 2019 | 94.6% | $6.98 Million | $380.00K | $7.21 Million | ▼ -0.9 pp |
| 2018 | 95.4% | $8.32 Million | $380.00K | $8.57 Million | ▲ +5.9 pp |
| 2017 | 89.5% | $3.62 Million | $380.00K | $6.59 Million | ▼ -1.1 pp |
| 2016 | 90.6% | $2.69 Million | $253.00K | $3.02 Million | ▲ +11.8 pp |
| 2015 | 78.8% | $4.89 Million | $1.04 Million | $5.32 Million | ▲ +32.2 pp |
| 2014 | 46.6% | $4.68 Million | $2.50 Million | $5.64 Million | ▼ -11.2 pp |
| 2013 | 57.8% | $6.79 Million | $2.87 Million | $8.02 Million | ▲ +9.6 pp |
| 2012 | 48.2% | $9.42 Million | $4.89 Million | $11.09 Million | ▲ +19.5 pp |
| 2011 | 28.7% | $3.44 Million | $2.46 Million | $4.07 Million | ▲ +18.3 pp |
| 2010 | 10.4% | $2.83 Million | $2.54 Million | $3.80 Million | ▼ -89.6 pp |
| 2009 | 100.0% | $7.00K | $0.00 | $715.00K | ▲ +0.0 pp |
| 2008 | 100.0% | $1.43 Million | $0.00 | $3.43 Million | ▲ +0.1 pp |
| 2007 | 99.9% | $8.56 Million | $11.00K | $14.13 Million | ▼ 0.0 pp |
| 2006 | 99.9% | $22.76 Million | $25.00K | $26.90 Million | ▲ +0.2 pp |
| 2005 | 99.7% | $11.25 Million | $39.00K | $15.15 Million | ▼ -0.3 pp |
| 2004 | 100.0% | $19.60 Million | $0.00 | $25.62 Million | ▲ +0.0 pp |
| 2003 | 100.0% | $20.61 Million | $0.00 | $24.85 Million | ▲ +0.0 pp |
| 2002 | 100.0% | $34.83 Million | $0.00 | $38.42 Million | — |